Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031522619> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2031522619 endingPage "2207" @default.
- W2031522619 startingPage "2201" @default.
- W2031522619 abstract "1-β-d-Arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) is a selective antiherpesviral agent that has been shown to be metabolically stable in mice. However, E-5-(2-bromovinyl)uracil (BVU) is the major metabolite found after dosing in animals other than mice. When BV-araU was given orally to germ-free rats, only small amounts of BVU were found in the plasma, suggesting an important role of enterobacteria in the formation of BVU. Then, the metabolism of BV-araU prodrugs was studied in specific-pathogen free rats to select oral prodrugs of BV-araU with enhanced metabolic stability. 5′-O-Ethyl BV-araU (Et-BV-araU) gave about a 2-fold higher BV-araU blood concentration 3 and 6 hr after administration than after oral dosing of BV-araU, while the level of BVU was lower. Other aliphatic alkyl prodrugs also gave a lower level of BVU, but did not give the same elevation in blood concentration of BV-araU as did Et-BV-araU. Dosing of 5′-O-acetyl BV-araU resulted in blood concentrations of BV-araU and BVU similar to those after oral administration of BV-araU. 5′-O-Aromatic alkyl prodrugs showed poor bioavailability. A nearly 2-fold higher urinary recovery rate was seen for Et-BV-araU than for BV-araU or 5′-O-acetyl BV-araU. The conversion of Et-BV-araU to BV-araU was demonstrated in vitro using rat liver extract in the presence of co-factors, although the reaction was slow. The 5′-O-aliphatic alkyl prodrugs were completely resistant to degradation by enterobacteria, whereas the esters were partially degraded to BVU. Et-BV-araU may be a useful oral prodrug of BV-araU due to its increased metabolic stability and bioavailability." @default.
- W2031522619 created "2016-06-24" @default.
- W2031522619 creator A5030921201 @default.
- W2031522619 creator A5038089178 @default.
- W2031522619 creator A5086848386 @default.
- W2031522619 creator A5088752894 @default.
- W2031522619 date "1993-12-01" @default.
- W2031522619 modified "2023-09-27" @default.
- W2031522619 title "Metabolism of 5′-ether prodrugs of 1-β-d-Arabinofuranosyl-E-5-(2-bromovinyl)uracil in rats" @default.
- W2031522619 cites W1969337210 @default.
- W2031522619 cites W1978713135 @default.
- W2031522619 cites W1990938465 @default.
- W2031522619 cites W1997107625 @default.
- W2031522619 cites W2006378984 @default.
- W2031522619 cites W2008655063 @default.
- W2031522619 cites W2049816820 @default.
- W2031522619 cites W2058685119 @default.
- W2031522619 cites W2081581581 @default.
- W2031522619 cites W2088433872 @default.
- W2031522619 cites W2137562741 @default.
- W2031522619 cites W2145090218 @default.
- W2031522619 cites W2275893205 @default.
- W2031522619 doi "https://doi.org/10.1016/0006-2952(93)90610-9" @default.
- W2031522619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8274153" @default.
- W2031522619 hasPublicationYear "1993" @default.
- W2031522619 type Work @default.
- W2031522619 sameAs 2031522619 @default.
- W2031522619 citedByCount "18" @default.
- W2031522619 countsByYear W20315226192012 @default.
- W2031522619 countsByYear W20315226192016 @default.
- W2031522619 countsByYear W20315226192017 @default.
- W2031522619 countsByYear W20315226192018 @default.
- W2031522619 countsByYear W20315226192019 @default.
- W2031522619 countsByYear W20315226192021 @default.
- W2031522619 countsByYear W20315226192022 @default.
- W2031522619 crossrefType "journal-article" @default.
- W2031522619 hasAuthorship W2031522619A5030921201 @default.
- W2031522619 hasAuthorship W2031522619A5038089178 @default.
- W2031522619 hasAuthorship W2031522619A5086848386 @default.
- W2031522619 hasAuthorship W2031522619A5088752894 @default.
- W2031522619 hasConcept C108215921 @default.
- W2031522619 hasConcept C181389837 @default.
- W2031522619 hasConcept C185592680 @default.
- W2031522619 hasConcept C2777477808 @default.
- W2031522619 hasConcept C2779554091 @default.
- W2031522619 hasConcept C552990157 @default.
- W2031522619 hasConcept C55493867 @default.
- W2031522619 hasConcept C62231903 @default.
- W2031522619 hasConcept C71240020 @default.
- W2031522619 hasConcept C86803240 @default.
- W2031522619 hasConcept C98274493 @default.
- W2031522619 hasConceptScore W2031522619C108215921 @default.
- W2031522619 hasConceptScore W2031522619C181389837 @default.
- W2031522619 hasConceptScore W2031522619C185592680 @default.
- W2031522619 hasConceptScore W2031522619C2777477808 @default.
- W2031522619 hasConceptScore W2031522619C2779554091 @default.
- W2031522619 hasConceptScore W2031522619C552990157 @default.
- W2031522619 hasConceptScore W2031522619C55493867 @default.
- W2031522619 hasConceptScore W2031522619C62231903 @default.
- W2031522619 hasConceptScore W2031522619C71240020 @default.
- W2031522619 hasConceptScore W2031522619C86803240 @default.
- W2031522619 hasConceptScore W2031522619C98274493 @default.
- W2031522619 hasIssue "12" @default.
- W2031522619 hasLocation W20315226191 @default.
- W2031522619 hasLocation W20315226192 @default.
- W2031522619 hasOpenAccess W2031522619 @default.
- W2031522619 hasPrimaryLocation W20315226191 @default.
- W2031522619 hasRelatedWork W2012134758 @default.
- W2031522619 hasRelatedWork W2032368516 @default.
- W2031522619 hasRelatedWork W2053402936 @default.
- W2031522619 hasRelatedWork W2075198269 @default.
- W2031522619 hasRelatedWork W2076052464 @default.
- W2031522619 hasRelatedWork W2086700810 @default.
- W2031522619 hasRelatedWork W2092357016 @default.
- W2031522619 hasRelatedWork W2279554812 @default.
- W2031522619 hasRelatedWork W3023756610 @default.
- W2031522619 hasRelatedWork W88005891 @default.
- W2031522619 hasVolume "46" @default.
- W2031522619 isParatext "false" @default.
- W2031522619 isRetracted "false" @default.
- W2031522619 magId "2031522619" @default.
- W2031522619 workType "article" @default.